Q1 2025 Natera Inc Earnings Call Transcript
Key Points
- Natera Inc (NTRA) reported a 37% year-over-year revenue growth, reaching $502 million in Q1 2025.
- The company processed 855,000 units in the quarter, marking a significant increase in women's health volumes and a record quarter for Signatera.
- Gross margins improved to 63%, with a notable increase of over 110 basis points compared to Q4 2024.
- Natera Inc (NTRA) raised its revenue guidance for 2025 to a range of $1.94 billion to $2.02 billion, reflecting strong growth expectations.
- The company generated $23 million in cash during the quarter, even while investing heavily in growth initiatives.
- Natera Inc (NTRA) faces potential risks from weather disruptions, as seen with the wildfires in Southern California affecting operations.
- The company acknowledges challenges in achieving reimbursement for certain tests, impacting average selling prices (ASPs).
- There is uncertainty regarding the timing of new guidelines for microdeletions and carrier screening, which could impact future revenue.
- Despite strong growth, the company is still in the early stages of market penetration, with significant room for expansion.
- Natera Inc (NTRA) faces competition in the MRD testing market, which could impact its market share and growth trajectory.
Welcome to Natera's 2025 first quarter financial results conference call. (Operator Instructions) As a reminder, this conference call is being recorded on May 8, 2025. I would now like to turn the conference call over to Michael Brophy, Chief Financial Officer. Please go ahead.
Thanks, operator. Good afternoon. Thank you for joining our conference call to discuss the results of our first quarter of 2025.
On the line, I'm joined by Steve Chapman, our CEO; and Solomon Moshkevich, President, Clinical Diagnostics; Alex Aleshin, General Manager of Oncology will be available for Q&A. Today's conference call is being broadcast live via webcast. We will be referring to a slide presentation that has been posted to investor.natera.com. A replay of the call will also be posted to our IR website as it's available.
Starting on slide 2. During the course of this conference call, we will be making forward-looking statements regarding future events and our anticipated future performance, such as our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
